Search Results 921-930 of 16521 for intermittent fasting optimization

  1. A Study of Insulin Synthesis and Secretion in Pre-diabetes - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

  3. A Study to Evaluate Food on Gastrointestinal Toxicity and The Effect of Selumetinib in Adolescents with Neurofibromatosis Type 1 - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers ... fasted conditions; and potentially, to confirm an appropriate dosing ...

  4. Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes - Mayo Clinic

    The purpose of this study is to demonstrate that Re-Cellularization therapy is superior to sham control for improving glycemic control in adults with type 2 ...

  5. Division of Endocrinology, Diabetes, Metabolism, and Nutrition-Research - Contact

    Contact the Division of Endocrinology, Diabetes, Metabolism, and Nutrition-Research at Mayo Clinic about our research on endocrine and metabolic disorders, ...

  6. Long Term Follow-Up of Subjects Exposed to GSK3377794 - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

  7. A Trial To Evaluate The Efficacy And Safety Of Ninerafaxstat In Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

  8. Polycystic Kidney Disease Archives - Mayo Clinic News Network

    ... diet and eating less protein. Controlling pain. Prompt treatment of bladder or kidney infections with antibiotics to prevent kidney damage. Preventing ...

  9. A Study Of NGM282 When Given To Subjects With Functional Constipation And To Healthy Individuals - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

  10. Nutrition Obesity Research Program - Overview

    The Nutrition Obesity Research Program at Mayo Clinic is poised to make a transformational change to address the complex health challenges of obesity and ...